142 related articles for article (PubMed ID: 7925522)
1. Chronic oral pretreatment with the angiotensin converting enzyme inhibitor, trandolapril decreases ventricular fibrillation in acute ischaemia and reperfusion.
Muller CA; Opie LH; Peisach M; Pineda CA
Eur Heart J; 1994 Jul; 15(7):988-96. PubMed ID: 7925522
[TBL] [Abstract][Full Text] [Related]
2. Combination of a calcium antagonist, verapamil, with an angiotensin converting enzyme inhibitor, trandolapril, in experimental myocardial ischemia and reperfusion: antiarrhythmic and hemodynamic effects of chronic oral pretreatment.
Muller CA; Opie LH; Pineda CA; McCarthy J; Kraljevic V
Cardiovasc Drugs Ther; 1998 Oct; 12(5):449-55. PubMed ID: 9926275
[TBL] [Abstract][Full Text] [Related]
3. Antiarrhythmic effects of the angiotensin converting enzyme inhibitor perindoprilat in a pig model of acute regional myocardial ischemia.
Muller CA; Opie LH; Peisach M; Pineda CA
J Cardiovasc Pharmacol; 1992 May; 19(5):748-54. PubMed ID: 1381773
[TBL] [Abstract][Full Text] [Related]
4. Does long-term angiotensin converting enzyme inhibition affect the concentration of tissue-type plasminogen activator-plasminogen activator inhibitor-1 in the blood of patients with a previous myocardial infarction.
Pedersen OD; Gram J; Jeunemaitre X; Billaud E; Jespersen J
Coron Artery Dis; 1997 May; 8(5):283-91. PubMed ID: 9285181
[TBL] [Abstract][Full Text] [Related]
5. Role of bradykinin and eNOS in the anti-ischaemic effect of trandolapril.
Cargnoni A; Comini L; Bernocchi P; Bachetti T; Ceconi C; Curello S; Ferrari R
Br J Pharmacol; 2001 May; 133(1):145-53. PubMed ID: 11325804
[TBL] [Abstract][Full Text] [Related]
6. Effects of trandolapril on cardiac angiotensin I converting enzyme activity in rats with chronic heart failure following myocardial infarction.
Sanbe A; Tsukada J; Takeo S
Jpn Heart J; 1995 Jul; 36(4):451-63. PubMed ID: 7474361
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment with angiotensin-converting enzyme inhibitors attenuates ischemia-reperfusion injury.
Lazar HL; Bao Y; Rivers S; Bernard SA
Ann Thorac Surg; 2002 May; 73(5):1522-7. PubMed ID: 12022543
[TBL] [Abstract][Full Text] [Related]
8. Enalapril protects against myocardial ischemia/reperfusion injury in a swine model of cardiac arrest and resuscitation.
Wang G; Zhang Q; Yuan W; Wu J; Li C
Int J Mol Med; 2016 Nov; 38(5):1463-1473. PubMed ID: 27633002
[TBL] [Abstract][Full Text] [Related]
9. The effects of Z13752A, a combined ACE/NEP inhibitor, on responses to coronary artery occlusion; a primary protective role for bradykinin.
Rastegar MA; Marchini F; Morazzoni G; Vegh A; Papp JG; Parratt JR
Br J Pharmacol; 2000 Feb; 129(4):671-80. PubMed ID: 10683191
[TBL] [Abstract][Full Text] [Related]
10. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group.
Køber L; Torp-Pedersen C; Carlsen JE; Bagger H; Eliasen P; Lyngborg K; Videbaek J; Cole DS; Auclert L; Pauly NC
N Engl J Med; 1995 Dec; 333(25):1670-6. PubMed ID: 7477219
[TBL] [Abstract][Full Text] [Related]
11. Effects of subchronic treatment with trandolapril and enalapril on cardiovascular morphologic alterations in the aged spontaneously hypertensive rat with heart failure.
Secchi J; Lecaque D; Dunn FW; Jouquey S; Auberval UD; Benzoni F; Sirugue O; Hamon G
J Cardiovasc Pharmacol; 1994; 23 Suppl 4():S30-7. PubMed ID: 7527099
[TBL] [Abstract][Full Text] [Related]
12. An endogenous protectant effect of cardiac cyclic GMP against reperfusion-induced ventricular fibrillation in the rat heart.
Pabla R; Bland-Ward P; Moore PK; Curtis MJ
Br J Pharmacol; 1995 Dec; 116(7):2923-30. PubMed ID: 8680726
[TBL] [Abstract][Full Text] [Related]
13. Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction.
Pedersen OD; Bagger H; Kober L; Torp-Pedersen C
Circulation; 1999 Jul; 100(4):376-80. PubMed ID: 10421597
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of a beta-adrenergic receptor antagonist, propranolol, in preventing ischaemic ventricular fibrillation: dependence on heart rate and ischaemia duration.
Aupetit JF; Frassati D; Bui-Xuan B; Freysz M; Faucon G; Timour Q
Cardiovasc Res; 1998 Mar; 37(3):646-55. PubMed ID: 9659448
[TBL] [Abstract][Full Text] [Related]
15. Dose-response studies with idrapril in the rat heart during acute myocardial ischaemia and reperfusion.
Riva E; Traquandi C
Eur J Pharmacol; 1996 Oct; 312(3):293-300. PubMed ID: 8894611
[TBL] [Abstract][Full Text] [Related]
16. Prevention of ventricular fibrillation by metoprolol in a pig model of acute myocardial ischaemia: absence of a major arrhythmogenic role for cyclic AMP.
Muller CA; Opie LH; Hamm CW; Peisach M; Gihwala D
J Mol Cell Cardiol; 1986 Apr; 18(4):375-87. PubMed ID: 3012099
[TBL] [Abstract][Full Text] [Related]
17. Preclinical considerations and results with the combination of verapamil and trandolapril: blood pressure reduction and beyond.
Kirchengast M
J Hypertens Suppl; 1997 Mar; 15(2):S27-33. PubMed ID: 9218195
[TBL] [Abstract][Full Text] [Related]
18. Effects of long-term treatment with trandolapril on sarcoplasmic reticulum function of cardiac muscle in rats with chronic heart failure following myocardial infarction.
Yamaguchi F; Sanbe A; Takeo S
Br J Pharmacol; 1998 Jan; 123(2):326-34. PubMed ID: 9489622
[TBL] [Abstract][Full Text] [Related]
19. Antiarrhythmic and metabolic effects of indoramin during acute regional ischemia and reperfusion in isolated rat heart.
Muller CA; Worthington MG; Thandroyen FT
J Cardiovasc Pharmacol; 1990 Mar; 15(3):408-13. PubMed ID: 1691364
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme inhibition after myocardial infarction: the Trandolapril Cardiac Evaluation Study.
Torp-Pedersen C; Køber L; Carlsen J
Am Heart J; 1996 Jul; 132(1 Pt 2 Su):235-43. PubMed ID: 8677862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
